Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Rhythm Pharmaceuticals (RYTM) Gross Profit: 2021-2024

Historic Gross Profit for Rhythm Pharmaceuticals (RYTM) over the last 4 years, with Dec 2024 value amounting to $116.8 million.

  • Rhythm Pharmaceuticals' Gross Profit rose 55.66% to $45.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $155.9 million, marking a year-over-year increase of 56.30%. This contributed to the annual value of $116.8 million for FY2024, which is 71.39% up from last year.
  • Rhythm Pharmaceuticals' Gross Profit amounted to $116.8 million in FY2024, which was up 71.39% from $68.1 million recorded in FY2023.
  • Rhythm Pharmaceuticals' Gross Profit's 5-year high stood at $116.8 million during FY2024, with a 5-year trough of $2.6 million in FY2021.
  • Over the past 3 years, Rhythm Pharmaceuticals' median Gross Profit value was $68.1 million (recorded in 2023), while the average stood at $68.8 million.
  • Data for Rhythm Pharmaceuticals' Gross Profit shows a peak YoY skyrocketed of 741.68% (in 2022) over the last 5 years.
  • Yearly analysis of 4 years shows Rhythm Pharmaceuticals' Gross Profit stood at $2.6 million in 2021, then surged by 741.68% to $21.5 million in 2022, then soared by 216.79% to $68.1 million in 2023, then skyrocketed by 71.39% to $116.8 million in 2024.